Department of Surgery, University of Alberta Hospital, 8440 112 Street NW, Edmonton, AB, T6G 2B7, Canada.
Obes Surg. 2021 Oct;31(10):4519-4527. doi: 10.1007/s11695-021-05641-1. Epub 2021 Aug 11.
The aims of this study were to (1) characterize the prevalence of hypoalbuminemia (HA), (2) compare complication rates among HA and non-HA patients, and (3) determine the influence of HA on postoperative complications and 30-day mortality among bariatric surgery patients.
Data was extracted from the MBSAQIP registry from 2015 to 2018. A presurgical serum albumin level of [Formula: see text] 3.5 g/dL was used to organize the patient population into HA and non-HA cohorts. Bivariate analysis and multivariable logistic regression modeling were used.
Of 590,971 patients, 42,618 (7.2%) were identified as having serum albumin levels [Formula: see text] 3.5 g/dL. HA patients were younger (44.0 + / - 11.9 vs. 44.5 + / - 12.0 years; p < 0.0001), were of increased BMI (48.5 + / - 9.0 kg/m vs. 45.1 + / - 7.7 kg/m; p < 0.0001), and had a lower baseline functional status (1.6% vs. 1.0% dependent or partially dependent; p < 0.0001). HA patients had more anastomotic leaks (0.46% vs. 0.38%; p = 0.02), deep surgical site infections (0.37% vs. 0.24%; p < 0.0001), and composite serious complications (4.4% vs. 3.3%; p < 0.0001). At 30-day post-operation, complications including need for reintervention (1.6% vs. 1.2%; p < 0.0001), readmission (4.8% vs. 3.7%; p < 0.0001), and mortality (0.14% vs. 0.086%; p = 0.001) were all more prevalent among HA patients. After functional status, HA was the strongest modifiable predictor of serious complications but was not predictive of 30-day mortality.
We identified HA as one of the greatest modifiable factors predictive of serious complications. Adoption of strategies to identify and improve preoperative serum albumin levels may reduce overall serious complications among elective bariatric surgery patients.
本研究旨在:(1)描述低蛋白血症(HA)的患病率;(2)比较 HA 和非 HA 患者的并发症发生率;(3)确定 HA 对减重手术患者术后并发症和 30 天死亡率的影响。
数据来自 2015 年至 2018 年 MBSAQIP 注册中心。术前血清白蛋白水平 [Formula: see text] 3.5 g/dL 用于将患者人群分为 HA 和非 HA 队列。采用双变量分析和多变量逻辑回归模型。
在 590971 名患者中,42618 名(7.2%)的血清白蛋白水平[Formula: see text] 3.5 g/dL。HA 患者年龄更小(44.0 + / - 11.9 岁比 44.5 + / - 12.0 岁;p<0.0001),BMI 更高(48.5 + / - 9.0 kg/m 比 45.1 + / - 7.7 kg/m;p<0.0001),基线功能状态更低(1.6%依赖或部分依赖比 1.0%;p<0.0001)。HA 患者吻合口漏的发生率更高(0.46%比 0.38%;p=0.02),深部手术部位感染的发生率更高(0.37%比 0.24%;p<0.0001),复合严重并发症的发生率更高(4.4%比 3.3%;p<0.0001)。术后 30 天,HA 患者的并发症发生率更高,包括需要再次干预(1.6%比 1.2%;p<0.0001)、再入院(4.8%比 3.7%;p<0.0001)和死亡率(0.14%比 0.086%;p=0.001)。HA 是术后 30 天死亡率的最强预测因素,但不是严重并发症的预测因素。
我们发现 HA 是预测严重并发症的最可改变因素之一。采用识别和改善术前血清白蛋白水平的策略,可能会降低择期减重手术患者的严重并发症发生率。